Treatment Challenges and Survival Analysis of Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Real World

CONTEXT: Advent of trastuzumab has brought tremendous changes in the survival of human epidermal growth factor receptor 2 (Her2)-positive breast cancer patients. Despite the availability of the drug, it is still out of reach for many patients. There is very limited real world data regarding treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Adusumilli, Praveen, Konatam, Meher Lakshmi, Gundeti, Sadashivudu, Bala, Stalin, Maddali, Lakshmi Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398102/
https://www.ncbi.nlm.nih.gov/pubmed/28469333
http://dx.doi.org/10.4103/0971-5851.203511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398102/
https://www.ncbi.nlm.nih.gov/pubmed/28469333
http://dx.doi.org/10.4103/0971-5851.203511

Ejemplares similares